4/19/2011

XenneX has formed a joint venture with BioTime, called LifeMap Sciences, that will develop a database of embryonic stem cell lines and molecular markers that can be used for research on regenerative medicine. The database will allow researchers to monitor the development of stem cell lines.

Related Summaries